Literature DB >> 28641386

The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex.

Isabella Barbiero1, Diana Peroni1, Marco Tramarin1, Chetan Chandola1, Laura Rusconi1, Nicoletta Landsberger2, Charlotte Kilstrup-Nielsen1.   

Abstract

CDKL5 is a protein kinase that plays a key role for neuronal functions as testified by the onset of complex neuronal dysfunctions in patients with genetic lesions in CDKL5. Here we identify a novel interactor of CDKL5, IQGAP1, a fundamental regulator of cell migration and polarity. In accordance with a functional role of this interaction, depletion of CDKL5 impairs cell migration and impedes the localization of IQGAP1 at the leading edge. Moreover, we demonstrate that CDKL5 is required for IQGAP1 to form a functional complex with its effectors, Rac1 and the microtubule plus end tracking protein CLIP170. These defects eventually impact on the microtubule association of CLIP170, thus deranging their dynamics. CLIP170 is a cellular target of the neurosteroid pregnenolone; by blocking CLIP170 in its active conformation, pregnenolone is capable of restoring the microtubule association of CLIP170 in CDKL5 deficient cells and rescuing morphological defects in neurons devoid of CDKL5. These findings provide novel insights into CDKL5 functions and pave the way for target-specific therapeutic strategies for individuals affected with CDKL5-disorder.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28641386     DOI: 10.1093/hmg/ddx237

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity.

Authors:  Maria Fazzari; Angelisa Frasca; Francesco Bifari; Nicoletta Landsberger
Journal:  RNA Biol       Date:  2019-06-23       Impact factor: 4.652

Review 2.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

3.  mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder.

Authors:  Antonia Gurgone; Riccardo Pizzo; Alessandra Raspanti; Giuseppe Chiantia; Sunaina Devi; Debora Comai; Noemi Morello; Federica Pilotto; Sara Gnavi; Leonardo Lupori; Raffaele Mazziotti; Giulia Sagona; Elena Putignano; Alessio Nocentini; Claudiu T Supuran; Andrea Marcantoni; Tommaso Pizzorusso; Maurizio Giustetto
Journal:  Neuropsychopharmacology       Date:  2022-08-09       Impact factor: 8.294

Review 4.  Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting.

Authors:  Isabella Barbiero; Massimiliano Bianchi; Charlotte Kilstrup-Nielsen
Journal:  J Neuroendocrinol       Date:  2021-09-08       Impact factor: 3.870

5.  Neuron-Type Specific Loss of CDKL5 Leads to Alterations in mTOR Signaling and Synaptic Markers.

Authors:  Ethan Schroeder; Li Yuan; Eunju Seong; Cheryl Ligon; Nicholas DeKorver; C B Gurumurthy; Jyothi Arikkath
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

6.  Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.

Authors:  Claudia Fuchs; Laura Gennaccaro; Stefania Trazzi; Stefano Bastianini; Simone Bettini; Viviana Lo Martire; Elisa Ren; Giorgio Medici; Giovanna Zoccoli; Roberto Rimondini; Elisabetta Ciani
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

Review 7.  Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

Authors:  Syouichi Katayama; Noriyuki Sueyoshi; Tetsuya Inazu; Isamu Kameshita
Journal:  Neural Plast       Date:  2020-06-05       Impact factor: 3.599

Review 8.  Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?

Authors:  Isabella Barbiero; Roberta De Rosa; Charlotte Kilstrup-Nielsen
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

9.  Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.

Authors:  Manuela Loi; Laura Gennaccaro; Claudia Fuchs; Stefania Trazzi; Giorgio Medici; Giuseppe Galvani; Nicola Mottolese; Marianna Tassinari; Roberto Rimondini Giorgini; Andrea Milelli; Elisabetta Ciani
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.